Share Price and Basic Stock Data
Last Updated: January 24, 2026, 3:50 pm
| PEG Ratio | -3.17 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
DCM Shriram Ltd operates in a diversified sector, with its stock currently priced at ₹1,095 and a market capitalization of ₹17,088 Cr. The company reported a revenue of ₹11,547 Cr for the fiscal year ending March 2023, which marked a significant increase from ₹9,627 Cr in the previous year. However, revenue is projected to slightly decline to ₹10,922 Cr for FY 2024 before rising to ₹12,077 Cr in FY 2025, according to reported figures. Quarterly sales have shown variability, with a high of ₹3,367 Cr in December 2024 but a notable dip to ₹2,708 Cr in September 2023. The operating profit margin (OPM) averaged around 9% during the latest reporting periods, indicating tight margins typical of the diversified industry. The company’s sales growth trajectory reflects its strategic positioning in various sectors, although fluctuations in quarterly performance highlight potential challenges in maintaining consistent demand.
Profitability and Efficiency Metrics
DCM Shriram’s profitability metrics reveal a mixed performance. The company recorded a net profit of ₹714 Cr for the trailing twelve months, with a return on equity (ROE) of 8.66% and return on capital employed (ROCE) of 11.4%. These figures are relatively low compared to industry benchmarks, suggesting potential areas for improvement in capital efficiency. The interest coverage ratio (ICR) stood at 9.63x, indicating the company comfortably covers its interest expenses. However, operating profit has fluctuated significantly, peaking at ₹554 Cr in December 2022 but declining to ₹114 Cr by September 2023. The drop in operating profit margin (OPM) to 4% in the latest quarter highlights challenges in cost management or pricing power. The company’s ability to stabilize these metrics will be crucial for enhancing investor confidence and overall financial health.
Balance Sheet Strength and Financial Ratios
DCM Shriram’s balance sheet exhibits a solid foundation, with total reserves amounting to ₹7,194 Cr against borrowings of ₹2,177 Cr, resulting in a low long-term debt-to-equity ratio of 0.19. This indicates a prudent approach to leverage, providing a cushion during economic downturns. The company reported total assets of ₹12,731 Cr and liabilities of ₹12,731 Cr, reflecting a balanced financial structure. The current ratio of 1.58 suggests adequate liquidity to meet short-term obligations, although the quick ratio of 0.71 indicates reliance on inventory to cover liabilities. Furthermore, the price-to-book value (P/BV) ratio stood at 2.41x, which is higher than the typical sector range, reflecting market confidence or overvaluation. The efficiency metrics, including a cash conversion cycle (CCC) of 121 days, suggest a need for improvement in working capital management, particularly in inventory and receivables management.
Shareholding Pattern and Investor Confidence
The shareholding pattern of DCM Shriram indicates a strong promoter presence, holding 66.53% of the company’s equity, which provides stability and aligns management interests with those of shareholders. Foreign institutional investors (FIIs) held 3.97% of shares, while domestic institutional investors (DIIs) accounted for 8.24%. The public shareholding stands at 20.54%, reflecting a moderate level of retail investor engagement. The decline in the number of shareholders from 58,415 in December 2022 to 60,864 in September 2025 indicates a consolidation of ownership, which can be interpreted as either a sign of confidence from existing investors or a lack of new investor interest. The stable promoter holding and increasing institutional presence may support a long-term bullish sentiment, although the high promoter stake could also raise concerns about governance and minority shareholder rights.
Outlook, Risks, and Final Insight
Looking ahead, DCM Shriram faces both opportunities and risks. The company’s diversified operations provide resilience against sector-specific downturns, yet the significant fluctuations in quarterly sales and profitability metrics could challenge its growth trajectory. Risks include potential cost pressures, given the declining OPM and rising expenses, particularly in the context of economic volatility. Additionally, the company must navigate its working capital management issues to enhance operational efficiency. On the upside, strengthening institutional ownership could lead to more robust governance practices and strategic initiatives. If DCM Shriram successfully leverages its diversified business model while addressing its efficiency challenges, it may enhance its market position and profitability in the coming years. Conversely, failure to manage costs and improve margins could hinder its growth potential.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NESCO Ltd | 8,062 Cr. | 1,144 | 1,639/842 | 19.5 | 397 | 0.57 % | 21.1 % | 15.8 % | 2.00 |
| DCM Shriram Ltd | 17,175 Cr. | 1,101 | 1,502/903 | 24.6 | 463 | 0.82 % | 11.4 % | 8.66 % | 2.00 |
| Balmer Lawrie & Company Ltd | 2,856 Cr. | 167 | 238/147 | 10.8 | 114 | 5.09 % | 14.8 % | 14.0 % | 10.0 |
| 3M India Ltd | 37,546 Cr. | 33,315 | 37,385/25,714 | 61.4 | 1,906 | 0.48 % | 40.5 % | 30.5 % | 10.0 |
| Industry Average | 16,409.75 Cr | 8,931.75 | 29.08 | 720.00 | 1.74% | 21.95% | 17.24% | 6.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,740 | 3,236 | 2,720 | 2,780 | 2,708 | 3,035 | 2,399 | 2,876 | 2,957 | 3,367 | 2,877 | 3,262 | 3,272 |
| Expenses | 2,470 | 2,682 | 2,374 | 2,614 | 2,594 | 2,590 | 2,134 | 2,629 | 2,776 | 2,871 | 2,472 | 2,958 | 2,963 |
| Operating Profit | 270 | 554 | 346 | 166 | 114 | 445 | 265 | 248 | 181 | 496 | 405 | 304 | 309 |
| OPM % | 10% | 17% | 13% | 6% | 4% | 15% | 11% | 9% | 6% | 15% | 14% | 9% | 9% |
| Other Income | 32 | 33 | 26 | 17 | 22 | 35 | 24 | 26 | 54 | 41 | 21 | 22 | 99 |
| Interest | 11 | 13 | 12 | 25 | 15 | 15 | 32 | 29 | 38 | 43 | 43 | 44 | 43 |
| Depreciation | 63 | 66 | 71 | 72 | 74 | 77 | 80 | 86 | 101 | 109 | 114 | 112 | 119 |
| Profit before tax | 228 | 509 | 289 | 86 | 47 | 389 | 177 | 158 | 96 | 386 | 270 | 170 | 246 |
| Tax % | 44% | 33% | 35% | 34% | 32% | 38% | 33% | 37% | 34% | 32% | 34% | 33% | 35% |
| Net Profit | 128 | 342 | 187 | 57 | 32 | 240 | 118 | 100 | 63 | 262 | 179 | 114 | 159 |
| EPS in Rs | 8.22 | 21.94 | 11.97 | 3.63 | 2.07 | 15.42 | 7.55 | 6.43 | 4.03 | 16.81 | 11.47 | 7.27 | 10.13 |
Last Updated: January 2, 2026, 12:03 am
Below is a detailed analysis of the quarterly data for DCM Shriram Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3,272.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,262.00 Cr. (Jun 2025) to 3,272.00 Cr., marking an increase of 10.00 Cr..
- For Expenses, as of Sep 2025, the value is 2,963.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,958.00 Cr. (Jun 2025) to 2,963.00 Cr., marking an increase of 5.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 309.00 Cr.. The value appears strong and on an upward trend. It has increased from 304.00 Cr. (Jun 2025) to 309.00 Cr., marking an increase of 5.00 Cr..
- For OPM %, as of Sep 2025, the value is 9.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 9.00%.
- For Other Income, as of Sep 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Jun 2025) to 99.00 Cr., marking an increase of 77.00 Cr..
- For Interest, as of Sep 2025, the value is 43.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 44.00 Cr. (Jun 2025) to 43.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 119.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 112.00 Cr. (Jun 2025) to 119.00 Cr., marking an increase of 7.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 246.00 Cr.. The value appears strong and on an upward trend. It has increased from 170.00 Cr. (Jun 2025) to 246.00 Cr., marking an increase of 76.00 Cr..
- For Tax %, as of Sep 2025, the value is 35.00%. The value appears to be increasing, which may not be favorable. It has increased from 33.00% (Jun 2025) to 35.00%, marking an increase of 2.00%.
- For Net Profit, as of Sep 2025, the value is 159.00 Cr.. The value appears strong and on an upward trend. It has increased from 114.00 Cr. (Jun 2025) to 159.00 Cr., marking an increase of 45.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 10.13. The value appears strong and on an upward trend. It has increased from 7.27 (Jun 2025) to 10.13, marking an increase of 2.86.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6,182 | 5,639 | 5,780 | 5,788 | 6,900 | 7,771 | 7,767 | 8,308 | 9,627 | 11,547 | 10,922 | 12,077 | 12,777 |
| Expenses | 5,673 | 5,240 | 5,276 | 5,017 | 5,866 | 6,402 | 6,575 | 7,156 | 7,831 | 9,941 | 9,932 | 10,747 | 11,263 |
| Operating Profit | 509 | 399 | 505 | 771 | 1,035 | 1,369 | 1,192 | 1,152 | 1,796 | 1,606 | 991 | 1,330 | 1,514 |
| OPM % | 8% | 7% | 9% | 13% | 15% | 18% | 15% | 14% | 19% | 14% | 9% | 11% | 12% |
| Other Income | 50 | 52 | 41 | 47 | 56 | 88 | 88 | 92 | 92 | 120 | 99 | 142 | 183 |
| Interest | 149 | 112 | 85 | 71 | 83 | 119 | 164 | 122 | 85 | 53 | 88 | 153 | 172 |
| Depreciation | 138 | 110 | 98 | 114 | 141 | 157 | 219 | 233 | 238 | 260 | 303 | 410 | 453 |
| Profit before tax | 272 | 228 | 362 | 633 | 867 | 1,180 | 897 | 889 | 1,565 | 1,413 | 699 | 909 | 1,071 |
| Tax % | 11% | 8% | 17% | 13% | 23% | 24% | 20% | 24% | 32% | 36% | 36% | 34% | |
| Net Profit | 242 | 211 | 301 | 552 | 669 | 904 | 722 | 674 | 1,067 | 911 | 447 | 604 | 714 |
| EPS in Rs | 14.85 | 12.98 | 18.58 | 33.97 | 41.22 | 56.99 | 45.96 | 43.17 | 68.45 | 58.41 | 28.67 | 38.75 | 45.68 |
| Dividend Payout % | 14% | 17% | 17% | 17% | 20% | 17% | 18% | 22% | 22% | 24% | 23% | 23% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -12.81% | 42.65% | 83.39% | 21.20% | 35.13% | -20.13% | -6.65% | 58.31% | -14.62% | -50.93% | 35.12% |
| Change in YoY Net Profit Growth (%) | 0.00% | 55.46% | 40.73% | -62.19% | 13.93% | -55.26% | 13.48% | 64.96% | -72.93% | -36.31% | 86.06% |
DCM Shriram Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 9% |
| 3 Years: | 8% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | -4% |
| 3 Years: | -18% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 28% |
| 3 Years: | 6% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 13% |
| 3 Years: | 10% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 2:40 am
Balance Sheet
Last Updated: December 4, 2025, 1:09 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 33 | 33 | 33 | 33 | 33 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| Reserves | 1,654 | 1,826 | 2,058 | 2,495 | 3,007 | 3,494 | 4,018 | 4,617 | 5,470 | 6,162 | 6,491 | 6,973 | 7,194 |
| Borrowings | 1,177 | 760 | 1,064 | 1,074 | 756 | 1,610 | 2,150 | 1,521 | 1,577 | 1,707 | 2,152 | 2,529 | 2,177 |
| Other Liabilities | 1,988 | 1,798 | 1,852 | 1,972 | 1,857 | 2,001 | 1,935 | 1,621 | 2,290 | 2,819 | 2,874 | 3,198 | 3,819 |
| Total Liabilities | 4,852 | 4,417 | 5,007 | 5,574 | 5,652 | 7,136 | 8,135 | 7,790 | 9,369 | 10,720 | 11,547 | 12,731 | 13,221 |
| Fixed Assets | 1,513 | 1,443 | 1,428 | 2,022 | 2,211 | 2,690 | 3,499 | 3,360 | 3,408 | 4,105 | 4,222 | 6,517 | 6,920 |
| CWIP | 51 | 62 | 357 | 65 | 117 | 332 | 59 | 109 | 494 | 1,630 | 2,615 | 834 | 821 |
| Investments | 203 | 6 | 35 | 31 | 30 | 31 | 29 | 30 | 3 | 12 | 54 | 56 | 73 |
| Other Assets | 3,085 | 2,906 | 3,186 | 3,457 | 3,294 | 4,084 | 4,548 | 4,291 | 5,463 | 4,973 | 4,656 | 5,324 | 5,406 |
| Total Assets | 4,852 | 4,417 | 5,007 | 5,574 | 5,652 | 7,136 | 8,135 | 7,790 | 9,369 | 10,720 | 11,547 | 12,731 | 13,221 |
Below is a detailed analysis of the balance sheet data for DCM Shriram Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 31.00 Cr..
- For Reserves, as of Sep 2025, the value is 7,194.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,973.00 Cr. (Mar 2025) to 7,194.00 Cr., marking an increase of 221.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2,177.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,529.00 Cr. (Mar 2025) to 2,177.00 Cr., marking a decrease of 352.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3,819.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,198.00 Cr. (Mar 2025) to 3,819.00 Cr., marking an increase of 621.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 13,221.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12,731.00 Cr. (Mar 2025) to 13,221.00 Cr., marking an increase of 490.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 6,920.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,517.00 Cr. (Mar 2025) to 6,920.00 Cr., marking an increase of 403.00 Cr..
- For CWIP, as of Sep 2025, the value is 821.00 Cr.. The value appears to be declining and may need further review. It has decreased from 834.00 Cr. (Mar 2025) to 821.00 Cr., marking a decrease of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 73.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Mar 2025) to 73.00 Cr., marking an increase of 17.00 Cr..
- For Other Assets, as of Sep 2025, the value is 5,406.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,324.00 Cr. (Mar 2025) to 5,406.00 Cr., marking an increase of 82.00 Cr..
- For Total Assets, as of Sep 2025, the value is 13,221.00 Cr.. The value appears strong and on an upward trend. It has increased from 12,731.00 Cr. (Mar 2025) to 13,221.00 Cr., marking an increase of 490.00 Cr..
Notably, the Reserves (7,194.00 Cr.) exceed the Borrowings (2,177.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 508.00 | -361.00 | 504.00 | 770.00 | -755.00 | 0.00 | -1.00 | 0.00 | 0.00 | 0.00 | 989.00 | -1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 69 | 81 | 63 | 48 | 49 | 51 | 23 | 34 | 27 | 22 | 28 |
| Inventory Days | 105 | 120 | 141 | 194 | 163 | 190 | 208 | 146 | 190 | 153 | 168 | 162 |
| Days Payable | 120 | 119 | 123 | 138 | 110 | 113 | 89 | 57 | 79 | 65 | 65 | 69 |
| Cash Conversion Cycle | 47 | 71 | 100 | 120 | 100 | 126 | 170 | 111 | 145 | 115 | 124 | 121 |
| Working Capital Days | 21 | 43 | 31 | 35 | 57 | 48 | 52 | 44 | 45 | 37 | 34 | 26 |
| ROCE % | 14% | 12% | 15% | 21% | 25% | 29% | 19% | 16% | 24% | 19% | 9% | 11% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Smallcap Fund | 344,909 | 0.51 | 43.19 | 339,557 | 2026-01-26 08:54:41 | 1.58% |
| UTI Large & Mid Cap Fund | 270,613 | 0.6 | 33.88 | 254,637 | 2026-01-25 07:25:46 | 6.27% |
| UTI Aggressive Hybrid Fund | 236,484 | 0.44 | 29.61 | 235,271 | 2026-01-25 23:41:29 | 0.52% |
| Baroda BNP Paribas Small Cap Fund | 150,000 | 1.54 | 18.78 | N/A | N/A | N/A |
| UTI Retirement Fund | 107,966 | 0.28 | 13.52 | 107,359 | 2026-01-25 12:18:54 | 0.57% |
| ICICI Prudential Commodities Fund | 16,243 | 0.06 | 2.03 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 38.75 | 28.67 | 58.41 | 68.45 | 43.17 |
| Diluted EPS (Rs.) | 38.75 | 28.67 | 58.41 | 68.45 | 43.17 |
| Cash EPS (Rs.) | 64.72 | 47.85 | 74.70 | 83.19 | 57.76 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 446.83 | 416.08 | 395.14 | 350.99 | 296.53 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 446.83 | 416.08 | 395.14 | 350.99 | 296.53 |
| Revenue From Operations / Share (Rs.) | 770.48 | 696.81 | 736.65 | 614.19 | 530.03 |
| PBDIT / Share (Rs.) | 93.93 | 69.49 | 110.12 | 120.47 | 79.39 |
| PBIT / Share (Rs.) | 67.77 | 50.16 | 93.52 | 105.29 | 64.51 |
| PBT / Share (Rs.) | 58.02 | 44.58 | 90.15 | 99.84 | 56.73 |
| Net Profit / Share (Rs.) | 38.55 | 28.52 | 58.11 | 68.01 | 42.89 |
| NP After MI And SOA / Share (Rs.) | 38.55 | 28.52 | 58.11 | 68.09 | 42.96 |
| PBDIT Margin (%) | 12.19 | 9.97 | 14.94 | 19.61 | 14.97 |
| PBIT Margin (%) | 8.79 | 7.19 | 12.69 | 17.14 | 12.17 |
| PBT Margin (%) | 7.52 | 6.39 | 12.23 | 16.25 | 10.70 |
| Net Profit Margin (%) | 5.00 | 4.09 | 7.88 | 11.07 | 8.09 |
| NP After MI And SOA Margin (%) | 5.00 | 4.09 | 7.88 | 11.08 | 8.10 |
| Return on Networth / Equity (%) | 8.62 | 6.85 | 14.70 | 19.40 | 14.48 |
| Return on Capital Employeed (%) | 11.19 | 8.95 | 17.97 | 23.60 | 16.93 |
| Return On Assets (%) | 4.74 | 3.87 | 8.49 | 11.39 | 8.64 |
| Long Term Debt / Equity (X) | 0.19 | 0.21 | 0.18 | 0.17 | 0.21 |
| Total Debt / Equity (X) | 0.34 | 0.31 | 0.26 | 0.27 | 0.27 |
| Asset Turnover Ratio (%) | 0.99 | 0.98 | 1.15 | 1.11 | 1.03 |
| Current Ratio (X) | 1.58 | 1.62 | 1.84 | 2.18 | 2.29 |
| Quick Ratio (X) | 0.71 | 0.64 | 0.90 | 1.21 | 1.30 |
| Inventory Turnover Ratio (X) | 4.41 | 2.09 | 2.04 | 1.92 | 1.68 |
| Dividend Payout Ratio (NP) (%) | 21.04 | 26.50 | 26.19 | 19.86 | -12.73 |
| Dividend Payout Ratio (CP) (%) | 12.53 | 15.80 | 20.37 | 16.24 | -9.46 |
| Earning Retention Ratio (%) | 78.96 | 73.50 | 73.81 | 80.14 | 0.00 |
| Cash Earning Retention Ratio (%) | 87.47 | 84.20 | 79.63 | 83.76 | 0.00 |
| Interest Coverage Ratio (X) | 9.63 | 12.44 | 32.69 | 22.12 | 10.20 |
| Interest Coverage Ratio (Post Tax) (X) | 4.95 | 6.11 | 18.25 | 13.49 | 6.51 |
| Enterprise Value (Cr.) | 18275.09 | 14894.61 | 12389.38 | 17624.91 | 7800.09 |
| EV / Net Operating Revenue (X) | 1.51 | 1.36 | 1.07 | 1.83 | 0.93 |
| EV / EBITDA (X) | 12.41 | 13.67 | 7.18 | 9.33 | 6.27 |
| MarketCap / Net Operating Revenue (X) | 1.40 | 1.23 | 1.02 | 1.84 | 0.94 |
| Retention Ratios (%) | 78.95 | 73.49 | 73.80 | 80.13 | 0.00 |
| Price / BV (X) | 2.41 | 2.07 | 1.89 | 3.22 | 1.69 |
| Price / Net Operating Revenue (X) | 1.40 | 1.23 | 1.02 | 1.84 | 0.94 |
| EarningsYield | 0.03 | 0.03 | 0.07 | 0.06 | 0.08 |
After reviewing the key financial ratios for DCM Shriram Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 38.75. This value is within the healthy range. It has increased from 28.67 (Mar 24) to 38.75, marking an increase of 10.08.
- For Diluted EPS (Rs.), as of Mar 25, the value is 38.75. This value is within the healthy range. It has increased from 28.67 (Mar 24) to 38.75, marking an increase of 10.08.
- For Cash EPS (Rs.), as of Mar 25, the value is 64.72. This value is within the healthy range. It has increased from 47.85 (Mar 24) to 64.72, marking an increase of 16.87.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 446.83. It has increased from 416.08 (Mar 24) to 446.83, marking an increase of 30.75.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 446.83. It has increased from 416.08 (Mar 24) to 446.83, marking an increase of 30.75.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 770.48. It has increased from 696.81 (Mar 24) to 770.48, marking an increase of 73.67.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 93.93. This value is within the healthy range. It has increased from 69.49 (Mar 24) to 93.93, marking an increase of 24.44.
- For PBIT / Share (Rs.), as of Mar 25, the value is 67.77. This value is within the healthy range. It has increased from 50.16 (Mar 24) to 67.77, marking an increase of 17.61.
- For PBT / Share (Rs.), as of Mar 25, the value is 58.02. This value is within the healthy range. It has increased from 44.58 (Mar 24) to 58.02, marking an increase of 13.44.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 38.55. This value is within the healthy range. It has increased from 28.52 (Mar 24) to 38.55, marking an increase of 10.03.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 38.55. This value is within the healthy range. It has increased from 28.52 (Mar 24) to 38.55, marking an increase of 10.03.
- For PBDIT Margin (%), as of Mar 25, the value is 12.19. This value is within the healthy range. It has increased from 9.97 (Mar 24) to 12.19, marking an increase of 2.22.
- For PBIT Margin (%), as of Mar 25, the value is 8.79. This value is below the healthy minimum of 10. It has increased from 7.19 (Mar 24) to 8.79, marking an increase of 1.60.
- For PBT Margin (%), as of Mar 25, the value is 7.52. This value is below the healthy minimum of 10. It has increased from 6.39 (Mar 24) to 7.52, marking an increase of 1.13.
- For Net Profit Margin (%), as of Mar 25, the value is 5.00. This value is within the healthy range. It has increased from 4.09 (Mar 24) to 5.00, marking an increase of 0.91.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.00. This value is below the healthy minimum of 8. It has increased from 4.09 (Mar 24) to 5.00, marking an increase of 0.91.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.62. This value is below the healthy minimum of 15. It has increased from 6.85 (Mar 24) to 8.62, marking an increase of 1.77.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.19. This value is within the healthy range. It has increased from 8.95 (Mar 24) to 11.19, marking an increase of 2.24.
- For Return On Assets (%), as of Mar 25, the value is 4.74. This value is below the healthy minimum of 5. It has increased from 3.87 (Mar 24) to 4.74, marking an increase of 0.87.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 0.2. It has decreased from 0.21 (Mar 24) to 0.19, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.34. This value is within the healthy range. It has increased from 0.31 (Mar 24) to 0.34, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.99. It has increased from 0.98 (Mar 24) to 0.99, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.58. This value is within the healthy range. It has decreased from 1.62 (Mar 24) to 1.58, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.64 (Mar 24) to 0.71, marking an increase of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.41. This value is within the healthy range. It has increased from 2.09 (Mar 24) to 4.41, marking an increase of 2.32.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 21.04. This value is within the healthy range. It has decreased from 26.50 (Mar 24) to 21.04, marking a decrease of 5.46.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.53. This value is below the healthy minimum of 20. It has decreased from 15.80 (Mar 24) to 12.53, marking a decrease of 3.27.
- For Earning Retention Ratio (%), as of Mar 25, the value is 78.96. This value exceeds the healthy maximum of 70. It has increased from 73.50 (Mar 24) to 78.96, marking an increase of 5.46.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.47. This value exceeds the healthy maximum of 70. It has increased from 84.20 (Mar 24) to 87.47, marking an increase of 3.27.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.63. This value is within the healthy range. It has decreased from 12.44 (Mar 24) to 9.63, marking a decrease of 2.81.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.95. This value is within the healthy range. It has decreased from 6.11 (Mar 24) to 4.95, marking a decrease of 1.16.
- For Enterprise Value (Cr.), as of Mar 25, the value is 18,275.09. It has increased from 14,894.61 (Mar 24) to 18,275.09, marking an increase of 3,380.48.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has increased from 1.36 (Mar 24) to 1.51, marking an increase of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 12.41. This value is within the healthy range. It has decreased from 13.67 (Mar 24) to 12.41, marking a decrease of 1.26.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.40, marking an increase of 0.17.
- For Retention Ratios (%), as of Mar 25, the value is 78.95. This value exceeds the healthy maximum of 70. It has increased from 73.49 (Mar 24) to 78.95, marking an increase of 5.46.
- For Price / BV (X), as of Mar 25, the value is 2.41. This value is within the healthy range. It has increased from 2.07 (Mar 24) to 2.41, marking an increase of 0.34.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.40, marking an increase of 0.17.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DCM Shriram Ltd:
- Net Profit Margin: 5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.19% (Industry Average ROCE: 21.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.62% (Industry Average ROE: 17.24%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.71
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.6 (Industry average Stock P/E: 29.08)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.34
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Diversified | 2nd Floor (West Wing), New Delhi Delhi 110037 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ajay S Shriram | Chairman & Sr.Mng.Director |
| Mr. Vikram S Shriram | Vice Chairman & Mng.Director |
| Mr. Ajit S Shriram | Joint Managing Director |
| Mr. Aditya A Shriram | Deputy Managing Director |
| Mr. K K Sharma | Whole Time Director |
| Mr. Pradeep Dinodia | Non Executive Director |
| Mr. Pravesh Sharma | Ind. Non-Executive Director |
| Justice(Retd) Vikramajit Sen | Ind. Non-Executive Director |
| Mr. Pranam Wahi | Ind. Non-Executive Director |
| Ms. Seema Bahuguna | Ind. Non-Executive Director |
| Dr. Simrit Kaur | Ind. Non-Executive Director |
| Mr. Vipin Sondhi | Ind. Non-Executive Director |
| Mr. Tejpreet Singh Chopra | Ind. Non-Executive Director |
| Mr. Rabinarayan Mishra | Nominee Director |
FAQ
What is the intrinsic value of DCM Shriram Ltd?
DCM Shriram Ltd's intrinsic value (as of 26 January 2026) is ₹733.74 which is 33.36% lower the current market price of ₹1,101.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹17,175 Cr. market cap, FY2025-2026 high/low of ₹1,502/903, reserves of ₹7,194 Cr, and liabilities of ₹13,221 Cr.
What is the Market Cap of DCM Shriram Ltd?
The Market Cap of DCM Shriram Ltd is 17,175 Cr..
What is the current Stock Price of DCM Shriram Ltd as on 26 January 2026?
The current stock price of DCM Shriram Ltd as on 26 January 2026 is ₹1,101.
What is the High / Low of DCM Shriram Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of DCM Shriram Ltd stocks is ₹1,502/903.
What is the Stock P/E of DCM Shriram Ltd?
The Stock P/E of DCM Shriram Ltd is 24.6.
What is the Book Value of DCM Shriram Ltd?
The Book Value of DCM Shriram Ltd is 463.
What is the Dividend Yield of DCM Shriram Ltd?
The Dividend Yield of DCM Shriram Ltd is 0.82 %.
What is the ROCE of DCM Shriram Ltd?
The ROCE of DCM Shriram Ltd is 11.4 %.
What is the ROE of DCM Shriram Ltd?
The ROE of DCM Shriram Ltd is 8.66 %.
What is the Face Value of DCM Shriram Ltd?
The Face Value of DCM Shriram Ltd is 2.00.